These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 26845288

  • 1. Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome).
    da Silva EM, Strufaldi MW, Andriolo RB, Silva LA.
    Cochrane Database Syst Rev; 2016 Feb 05; 2(2):CD008185. PubMed ID: 26845288
    [Abstract] [Full Text] [Related]

  • 2. Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome).
    da Silva EM, Strufaldi MW, Andriolo RB, Silva LA.
    Cochrane Database Syst Rev; 2014 Jan 08; (1):CD008185. PubMed ID: 24399699
    [Abstract] [Full Text] [Related]

  • 3. Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome).
    da Silva EM, Strufaldi MW, Andriolo RB, Silva LA.
    Cochrane Database Syst Rev; 2011 Nov 09; (11):CD008185. PubMed ID: 22071845
    [Abstract] [Full Text] [Related]

  • 4. Enzyme replacement therapy with laronidase (Aldurazyme(®)) for treating mucopolysaccharidosis type I.
    Jameson E, Jones S, Remmington T.
    Cochrane Database Syst Rev; 2016 Apr 01; 4():CD009354. PubMed ID: 27033167
    [Abstract] [Full Text] [Related]

  • 5. Enzyme replacement therapy with laronidase (Aldurazyme(®)) for treating mucopolysaccharidosis type I.
    Jameson E, Jones S, Wraith JE.
    Cochrane Database Syst Rev; 2013 Nov 21; (11):CD009354. PubMed ID: 24257962
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phase I/II clinical trial of enzyme replacement therapy with idursulfase beta in patients with mucopolysaccharidosis II (Hunter syndrome).
    Sohn YB, Cho SY, Park SW, Kim SJ, Ko AR, Kwon EK, Han SJ, Jin DK.
    Orphanet J Rare Dis; 2013 Mar 18; 8():42. PubMed ID: 23497636
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The relationship between anti-idursulfase antibody status and safety and efficacy outcomes in attenuated mucopolysaccharidosis II patients aged 5 years and older treated with intravenous idursulfase.
    Barbier AJ, Bielefeld B, Whiteman DA, Natarajan M, Pano A, Amato DA.
    Mol Genet Metab; 2013 Nov 18; 110(3):303-10. PubMed ID: 23988379
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Safety and efficacy of enzyme replacement therapy with idursulfase beta in children aged younger than 6 years with Hunter syndrome.
    Sohn YB, Cho SY, Lee J, Kwun Y, Huh R, Jin DK.
    Mol Genet Metab; 2015 Feb 18; 114(2):156-60. PubMed ID: 25219292
    [Abstract] [Full Text] [Related]

  • 18. Enzyme replacement therapy for infantile-onset Pompe disease.
    Chen M, Zhang L, Quan S.
    Cochrane Database Syst Rev; 2017 Nov 20; 11(11):CD011539. PubMed ID: 29155436
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.